NewsCase.com Financial Intelligence
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks
Menu
  • Market Analysis
  • Defense & Aerospace
  • AI & Tech
  • Banking & Finance
  • Crypto
  • European Stocks

Search NewsCase

HomePharma & Biotech

Pharma & Biotech

  • AI & Quantum Computing
  • Analysis
  • Anime
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds

    MacroGenics Investors Face a Waiting Game as Key Catalysts Shift to 2026

    Analysis March 27, 2026

    AbbVie Showcases Aesthetic Innovations and Strong Financials at Monaco Conference

    Earnings March 27, 2026

    Johnson & Johnson Strengthens Pipeline with First-of-its-Kind Oral Psoriasis Drug

    Earnings March 27, 2026

    Arbutus Biopharma Sets Sights on Capital Return Following Landmark Settlement

    Analysis March 26, 2026

    Valneva’s Statistical Hurdle Casts Shadow Over Promising Lyme Disease Vaccine

    Analysis March 26, 2026

    BioNTech’s Strategic Pivot Gains Momentum with Key Oncology Data

    Healthcare March 26, 2026

    Moderna’s Strategic Pivot: Building a Post-Pandemic Future on mRNA Expertise

    Healthcare March 26, 2026

    Evotec Faces Critical Investor Scrutiny with April Report

    Analysis March 25, 2026
    1...151617...85Page 16 of 85

    About NewsCase

    Professional financial news and analysis for active traders and investors. We cover global markets, stocks, cryptocurrencies, and investment strategies with in-depth research and real-time market data.

    Recent News

    • Micron’s AI Memory Monopoly Tightens as HBM4 Production Races Ahead of Earnings
    • Vanguard All-World ETF Hovers Just 0.62% From All-Time High — But Growing Fee Pressure Threatens Its Edge
    • SK Hynix's 308% Rally Draws South Korean Regulator's Ire as Talent War With Intel Heats Up
    • KNDS Races to Scale Up Production as Political Tensions Cap €5bn IPO Price
    • Nvidia’s Rubin Platform Moves to Mass Production as a Dedicated ETF Opens the Floodgates

    Categories

    • AI & Quantum Computing
    • Analysis
    • Banking & Insurance
    • Defense & Aerospace

    Company Info

    DNV Media GmbH

    Bornheimer Str. 180
    53119 Bonn, Germany
    Phone: +49 (0) 228 28627461
    Email: info@newscase.com

    Privacy Policy Terms of Service Imprint Disclaimer Contact

    © 2026 NewsCase.com · DNV Media GmbH